Belleville, WI, United States of America

Matt Staeben

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2008-2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Matt Staeben

Introduction

Matt Staeben, based in Belleville, Wisconsin, is an accomplished inventor recognized for his significant contributions to the field of biomedical research through his innovative patented methods. With a total of four patents to his name, Staeben is making strides in the area of group transfer reactions, which holds important implications for various biochemical applications.

Latest Patents

Staeben's latest patents include groundbreaking advancements related to antibodies and their applications in assays. One key patent is centered around an assay method for group transfer reactions. This invention discloses an isolated antibody produced against a donor product of an enzymatically catalyzed group transfer reaction. Specifically, the antibody is designed to preferentially recognize the donor product guanosine diphosphate (GDP) even in the presence of the donor molecule guanosine triphosphate (GTP). In addition to this, the patent encompasses immunoassays involving such antibodies along with kits for executing the immunoassays.

Another notable patent by Staeben is focused on an antibody that binds uridine diphosphate. This invention relates to methods for the detection, quantification, and high-throughput screening of donor products, as well as the catalytic activities that generate these donor products during group transfer reactions. The patent further includes immunoassays, antibodies, and kits that facilitate the practical application of these methods.

Career Highlights

Staeben is currently affiliated with Bellbrook Labs, LLC, where he collaborates on various research projects that bridge the gap between invention and application in the life sciences industry. His innovative mindset and commitment to research have led to substantial advancements beneficial to both scientific understanding and practical applications.

Collaborations

Throughout his career, Staeben has worked alongside notable colleagues including Robert G. Lowery and Karen Kleman-Leyer. These collaborations have not only fostered a productive working environment but also enhanced the innovation process through shared expertise and varied perspectives.

Conclusion

Matt Staeben continues to be a prominent figure in the inventory of biotechnological inventions, with his work making a significant impact on the field. His patents are a testament to his dedication to research and innovation, and his contributions are likely to influence future developments in biochemical assays and related applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…